Observed every year on 21 March, Cluster Headache Awareness Day is on the day of the equinox - "Cluster headache has a strong biorhythmicity, therefore cluster headache patients know this date from which on daytime in Europe will be longer than nighttime which is a relief for at least some sufferers".
The Journal of Headache and Pain is joining the campaign with some highly influential research content to complement this year's theme, Sharing a painless future for Cluster Headache.
A subset of patients does not respond to established pharmacological therapy. This study examines outcomes of a cohort of mainly chronic Cluster Headache patients treated with sphenopalatine ganglion (SPG) stimulation.
Read more about the outcomes
This systematic review aims to collect and summarize the level of evidence supporting the use of sphenopalatine ganglion block, radiofrequency ablation and neurostimulation in the treatment of head and facial pain.
Read more about this review
​​​​​​​​​​​​​​This study evaluates the association between Cluster Headache and the Hypocretin Receptor 2, Alcohol Dehydrogenase 4 and CLOCK (Circadian Locomotor Output Cycles Kaput) genes in a Chinese Cluster Headache case–control sample.
Read more about this study
This study aims to characterize comorbid conditions in a cohort of Cluster Headache patients diagnosed by headache experts, using electronic health record information from the Partners Research Patient Data Registry (RPDR).
Read more about this study
This study explores how greater occipital nerve injections represent a rapid and well-tolerated therapeutic option, which is widely used in clinical practice in adults, and has previously shown a good outcome in a pediatric population. Read more about this study